miR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis

Oncotarget

Volumn 7, Issue 1, 2016, Pages 7-22

  Almeida, Maria Ines ^a,b   Silva, Andreia Machado ^a,b,c   Vasconcelos, Daniel Marques ^a,b,c   Almeida, Catarina Rodrigues ^a,b   Caires, Hugo ^a,b   Pinto, Marta Teixeira ^a,c   Calin, George Adrian ^d   Santos, Susana Gomes ^a,b,c   Barbosa, Mário Adolfo ^a,b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Differentiation; Gerotarget; Mesenchymal stromal stem cells; MicroRNAs; VEGF

Indexed keywords

ALKALINE PHOSPHATASE; MICRORNA; MICRORNA 195; MICRORNA 497; UNCLASSIFIED DRUG; VASCULOTROPIN; MIRN195 MICRORNA, HUMAN; MIRN195 MICRORNA, MOUSE; MIRN497 MICRORNA, HUMAN; MIRN497 MICRORNA, MOUSE; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLOOD VESSEL; BONE CANCER CELL LINE; BONE DEVELOPMENT; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHORIOALLANTOIC MEMBRANE ASSAY; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; LUCIFERASE ASSAY; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MICROARRAY ANALYSIS; MICRORNA ARRAY; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; ANIMAL; CELL CULTURE; CELL LINE; CHICK EMBRYO; CHORIOALLANTOIS; CYTOLOGY; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; GENE EXPRESSION PROFILING; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPECIES SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84969765513     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/ONCOTARGET.6589     Document Type: Article

References (46)

1. Watson L, Elliman SJ, Coleman CM. From isolation to implantation: a concise review of mesenchymal stem cell therapy in bone fracture repair. Stem Cell Res Ther. 2014; 5:51
2. Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014; 15:1009-16
3. Gaston MS, Simpson AH. Inhibition of fracture healing. J Bone Joint Surg Br. 2007; 89:1553-60
4. Victoria G, Petrisor B, Drew B, Dick D. Bone stimulation for fracture healing: What's all the fuss? Indian J Orthop. 2009; 43:117-20
5. Gómez-Barrena E, Rosset P, Lozano D, Stanovici J, Ermthaller C, Gerbhard F. Bone fracture healing: cell therapy in delayed unions and nonunions. Bone. 2015; 70:93-101
6. Antebi B, Pelled G, Gazit D. Stem cell therapy for osteoporosis. Curr Osteoporos Rep. 2014; 12:41-7
7. Ito H. Clinical considerations of regenerative medicine in osteoporosis. Curr Osteoporos Rep. 2014; 12:230-4
8. Undale AH, Westendorf JJ, Yaszemski MJ, Khosla S. Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc. 2009; 84:893-902
9. Gruber R, Koch H, Doll BA, Tegtmeier F, Einhorn TA, Hollinger JO. Fracture healing in the elderly patient. Exp Gerontol. 2006; 41:1080-93
10. Almeida MI, Reis RM, Calin GA. MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res. 2011; 717:1-8
11. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Ørum H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010; 327:198-201
12. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, et al. Treatment of HCV infection by targeting microRNA. N Engl J. Med 2013; 368:1685-94
13. Beavers KR, Nelson CE, Duvall CL. MiRNA inhibition in tissue engineering and regenerative medicine. Adv Drug Deliv Rev. 2014; S0169-409X(14)00311-1
14. Maes C, Clemens TL. Angiogenic-osteogenic coupling: the endothelial perspective. Bonekey Rep. 2014; 3:578
15. Saran U, Gemini Piperni S, Chatterjee S. Role of angiogenesis in bone repair. Arch Biochem Biophys. 2014; 561:109-17
16. Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature. 2014; 507:323-8
17. Ramasamy SK, Kusumbe AP, Wang L, Adams RH. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature. 2014; 507:376-80
18. Stegen S, van Gastel N, Carmeliet G. Bringing new life to damaged bone: the importance of angiogenesis in bone repair and regeneration. Bone. 2015; 70:19-27
19. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotentmesenchymal precursor cell line C2C12. Mol Cell Biol. 2000; 20:8783-92
20. Yang X, Castilla LH, Xu X, Li C, Gotay J, Weinstein M, Liu PP, Deng CX. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development. 1999; 126:1571-80
21. Hassan MQ, Tare R, Lee SH, Mandeville M, Weiner B, Montecino M, van Wijnen AJ, Stein JL, Stein GS, Lian JB. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes. Mol Cell Biol. 2007; 27:3337-52
22. Zou Z, Zhang Y, Hao L, Wang F, Liu D, Su Y, Sun H. More insight into mesenchymal stem cells and their effects inside the body. Expert Opin Biol Ther. 2010; 10:215-30
23. Zhang JF, Fu WM, He ML, Xie WD, Lv Q, Wan G, Li G, Wang H, Lu G, Hu X, Jiang S, Li JN, Lin MC, et al. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol. 2011; 8:829-38
24. Mor E, Shomron N. Species-specific microRNA regulation influences phenotypic variability: perspectives on speciesspecific microRNA regulation. Bioessays. 2013; 35:881-8
25. Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem. 2009; 284:15676-84
26. Kapinas K, Kessler CB, Delany AM. miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem. 2009; 108:216-24
27. Grünhagen J, Bhushan R, Degenkolbe E, Jäger M, Knaus P, Mundlos S, Robinson PN, Ott CE. MiR-497-195 cluster microRNAs regulate osteoblast differentiation by targeting BMP signaling. J Bone Miner Res. 2015; 30:796-808
28. Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, et al. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology. 2012; 142:886-896.e9
29. Amer M, Elhefnawi M, El-Ahwany E, Awad AF, Gawad NA, Zada S, Tawab FM. Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span. Tumour Biol. 2014; 35:11301-9
30. Jiang HL, Yu H, Ma X, Xu D, Lin GF, Ma DY, Jin JZ. MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells. Tumour Biol. 2014; 35:6955-60
31. Fu MG, Li S, Yu TT, Qian LJ, Cao RS, Zhu H, Xiao B, Jiao CH, Tang NN, Ma JJ, Hua J, Zhang WF, Zhang HJ, Shi RH. Differential expression of miR-195 in esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and invasion by targeting of Cdc42. FEBS Lett. 2013; 587:3471-9
32. Guo H, Li W, Zheng T, Liu Z. MiR-195 targets HDGF to inhibit proliferation and invasion of NSCLC cells. Tumour Biol. 2014; 35:8861-6
33. Wang X, Wang Y, Lan H, Li J. MiR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R. Tumour Biol. 2014; 35:8765-70
34. Liu B, Qu J, Xu F, Guo Y, Wang Y, Yu H, Qian B. MiR-195 suppresses non small cell lung cancer by targeting CHEK1. Oncotarget. 2015; 6:9445-56. doi: 10.18632/oncotarget.3255
35. Wang L, Qian L, Li X, Yan J. MicroRNA-195 inhibits colorectal cancer cell proliferation, colony-formation and invasion through targeting CARMA3. Mol Med Rep. 2014; 10:473-8
36. Wallner C, Schira J, Wagner JM, Schulte M, Fischer S, Hirsch T, Richter W, Abraham S, Kneser U, Lehnhardt M, Behr B. Application of VEGFA and FGF-9 Enhances Angiogenesis, Osteogenesis and Bone Remodeling in Type 2Diabetic Long Bone Regeneration. PLoS One. 2015; 10:e0118823
37. Schmidt-Bleek K, Kwee BJ, Mooney DJ, Duda G. Boon and bane of inflammation in bone tissue regeneration and its link with angiogenesis. Tissue Eng Part B Rev. 2015; 21:354-64
38. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, et al. FilvaroffEH. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A. 2002; 99:9656-61
39. Liu Y, Berendsen AD, Jia S, Lotinun S, Baron R, Ferrara N, Olsen BR. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. J Clin Invest. 2012; 122:3101-13
40. Berendsen AD, Olsen BR. How vascular endothelial growth factor-A (VEGF) regulates differentiation of mesenchymal stem cells. J Histochem Cytochem. 2014; 62:103-8
41. Zhang Y, Wang Z, Gemeinhart RA. Progress in microRNA delivery. J Control Release. 2013; 172:962-74
42. Almeida CR, Vasconcelos DP, Gonçalves RM, Barbosa MA. Enhanced mesenchymal stromal cell recruitment via natural killer cells by incorporation of inflammatory signals in biomaterials. J R Soc Interface. 2012; 9:261-71
43. Silva AM, Oliveira MI, Sette L, Almeida CR, Oliveira MJ, Barbosa MA, Santos SG. Resveratrol as a natural antitumor necrosis factor-a molecule: implications to dendritic cells and their crosstalk with mesenchymal stromal cells. PLoS One. 2014; 9:e91406
44. Vasconcelos DM, Falentin-Daudré C, Blanquaert D, Thomas D, Granja PL, Migonney V. Role of protein environment and bioactive polymer grafting in the S. epidermidis response to titanium alloy for biomedical applications. Mater Sci Eng C Mater Biol Appl. 2014; 45:176-83
45. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, PfafflMW, Shipley GL, Vandesompele J, Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative realtime PCR experiments. Clin Chem. 2009; 55:611-22
46. Caires, HR, Gomez-Lazaro, M, Oliveira, C, Gomes, D, Mateus, DD, Oliveira, C, Barrias, CC, Barbosa, MA, Almeida, CR. Finding and tracing human MSC in 3D microenvironments with the photoconvertible protein Dendra2. Sci Rep. 2015; 5:10079